Research ArticleClinical Investigations
Repeatability of 18F-FDG PET/CT in Advanced Non–Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials
Wolfgang A. Weber, Constantine A. Gatsonis, P. David Mozley, Lucy G. Hanna, Anthony F. Shields, Denise R. Aberle, Ramaswamy Govindan, Drew A. Torigian, Joel S. Karp, Jian Q. (Michael) Yu, Rathan M. Subramaniam, Robert A. Halvorsen and Barry A. Siegel; for the ACRIN 6678 and MK-0646-008 Research teams
Journal of Nuclear Medicine August 2015, 56 (8) 1137-1143; DOI: https://doi.org/10.2967/jnumed.114.147728
Wolfgang A. Weber
1Memorial Sloan Kettering Cancer Center, New York, New York
Constantine A. Gatsonis
2Department of Biostatistics and Center for Statistical Sciences, Brown University, Providence, Rhode Island
P. David Mozley
3Merck & Co., Whitehouse Station, New Jersey
Lucy G. Hanna
2Department of Biostatistics and Center for Statistical Sciences, Brown University, Providence, Rhode Island
Anthony F. Shields
4Karmanos Cancer Institute, Wayne State University, Detroit, Michigan
Denise R. Aberle
5University of California-Los Angeles, Los Angeles, California
Ramaswamy Govindan
6Division of Oncology and the Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
Drew A. Torigian
7Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Joel S. Karp
7Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Jian Q. (Michael) Yu
8Fox Chase Cancer Center, Philadelphia, Pennsylvania
Rathan M. Subramaniam
9Russell H. Morgan Department of Radiology and Radiological Science and Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, Maryland
Robert A. Halvorsen
10Virginia Commonwealth University, Richmond, Virginia; and
Barry A. Siegel
11Mallinckrodt Institute of Radiology and the Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 56, Issue 8
August 1, 2015
Repeatability of 18F-FDG PET/CT in Advanced Non–Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials
Wolfgang A. Weber, Constantine A. Gatsonis, P. David Mozley, Lucy G. Hanna, Anthony F. Shields, Denise R. Aberle, Ramaswamy Govindan, Drew A. Torigian, Joel S. Karp, Jian Q. (Michael) Yu, Rathan M. Subramaniam, Robert A. Halvorsen, Barry A. Siegel
Journal of Nuclear Medicine Aug 2015, 56 (8) 1137-1143; DOI: 10.2967/jnumed.114.147728
Repeatability of 18F-FDG PET/CT in Advanced Non–Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials
Wolfgang A. Weber, Constantine A. Gatsonis, P. David Mozley, Lucy G. Hanna, Anthony F. Shields, Denise R. Aberle, Ramaswamy Govindan, Drew A. Torigian, Joel S. Karp, Jian Q. (Michael) Yu, Rathan M. Subramaniam, Robert A. Halvorsen, Barry A. Siegel
Journal of Nuclear Medicine Aug 2015, 56 (8) 1137-1143; DOI: 10.2967/jnumed.114.147728
Jump to section
Related Articles
Cited By...
- 18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma
- Quantitative Test-Retest Measurement of 68Ga-PSMA-HBED-CC in Tumor and Normal Tissue
- Use of a Qualification Phantom for PET Brain Imaging in a Multicenter Consortium: A Collaboration Between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network
- Test-Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network
- The Influence of Minimal Misalignment on the Repeatability of PET Images Examined by the Repositioning of Point Sources
- Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study
- Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
- 18F-FDG PET/CT for Very Early Response Evaluation Predicts CT Response in Erlotinib-Treated Non-Small Cell Lung Cancer Patients: A Comparison of Assessment Methods
- Test-Retest Variability in Lesion SUV and Lesion SUR in 18F-FDG PET: An Analysis of Data from Two Prospective Multicenter Trials
- Quantitation of Cancer Treatment Response by 18F-FDG PET/CT: Multicenter Assessment of Measurement Variability
- Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials
- Repeatability of SUV in Oncologic 18F-FDG PET
- Repeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma
- Reliability of PET/CT Shape and Heterogeneity Features in Functional and Morphologic Components of Non-Small Cell Lung Cancer Tumors: A Repeatability Analysis in a Prospective Multicenter Cohort
- Repeatability of Quantitative 18F-NaF PET: A Multicenter Study
- Does PET SUV Harmonization Affect PERCIST Response Classification?
- Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients
- Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size
- SUVpeak Performance in Lung Cancer: Comparison to Average SUV from the 40 Hottest Voxels
- Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV
- Reply: Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV
- The Value of Establishing the Quantitative Accuracy of PET/CT Imaging